Patient-centred and economic effectiveness of a decision aid for patients with age-related cataract in China: study protocol of a randomised controlled trial. by Zheng, Y et al.
1Zheng Y, et al. BMJ Open 2020;0:e032242. doi:10.1136/bmjopen-2019-032242
Open access 
Patient- centred and economic 
effectiveness of a decision aid for 
patients with age- related cataract in 
China: study protocol of a randomised 
controlled trial
Yingfeng Zheng   ,1 Bo Qu,1 Ling Jin,1 Chunxiao Wang,1 Yuxin Zhong,1 
Mingguang He,1,2 Yizhi Liu1
To cite: Zheng Y, Qu B, Jin L, 
et al.  Patient- centred and 
economic effectiveness of a 
decision aid for patients with 
age- related cataract in China: 
study protocol of a randomised 
controlled trial. BMJ Open 
2020;0:e032242. doi:10.1136/
bmjopen-2019-032242
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
032242).
YZ and BQ contributed equally.
Received 11 June 2019
Revised 06 March 2020
Accepted 03 April 2020
1State Key Laboratory of 
Ophthalmology, Zhongshan 
Ophthalmic Center, Sun Yat- Sen 
University, Guangzhou, China
2Centre for Eye Research 
Australia, Royal Victorian Eye 
and Ear Hospital, University of 
Melbourne, Melbourne, Victoria, 
Australia
Correspondence to
Professor Yingfeng Zheng;  
 zhyfeng@ mail. sysu. edu. cn
Protocol
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
Strengths and limitations of this study
 ► The feasibility of implementing shared decision 
making in China has not been formally evaluated. 
The current study will be the first attempt to conduct 
a randomised controlled trial to evaluate the effec-
tiveness of a patient decision aid in China.
 ► The community- based trial will provide evidence on 
the generalisability of the findings within the context 
of the community environment.
 ► Vision function, health- related quality of life and 
economic evaluation will be assessed 1 year after 
the intervention.
 ► The data will be collected by an independent non- 
profit company.
 ► The use of printed patient decision aid booklet pre-
cludes the possibility of directly conveying informa-
tion to persons with reading difficulties.
AbStrACt
Introduction The need for cataract surgery is on the rise 
due to our ageing population and high demands for greater 
visual functioning. Although the majority of patients want 
to participate in a shared decision- making process, no 
decision aid has been available to improve the quality of 
decision. The present study aims to determine whether a 
decision aid increases informed decision about cataract 
surgery.
Methods and analysis A parallel randomised controlled trial 
(772 participants) will be conducted. The decision aid will be 
implemented among patients with any age- related cataract 
in Yuexiu District, which is socioeconomically representative 
of a major metropolitan region in Southern China. Participants 
will be randomly assigned to receive either a patient decision 
aid or a traditional booklet, and they will complete three 
surveys: (1) baseline assessment before the intervention 
(time point (T)1), 2 weeks (T2) and 1 year (T3) after the 
intervention. The control group receives a traditional booklet 
with standard general information developed by the National 
Eye Institute to help patients understand cataract, whereas 
the intervention group receives a patient decision aid that 
includes not only the standard general information, but also 
the quantitative risk information on the possible outcomes 
of cataract surgery as well as value clarification exercise. 
The primary study outcome is the informed decision, the 
percentage of patients who have adequate knowledge and 
demonstrate consistency between attitudes and intentions. 
Secondary outcomes include perceived importance of 
cataract surgery benefits/harms, decision conflict and 
confidence, anticipated regret and booklet utilisation and 
acceptability at 2 weeks, and surgical rates and a cost–utility 
estimate of the decision aid at 1 year.
Ethics and dissemination Ethics approval was obtained 
from the Ethics Committee of Zhongshan Ophthalmic 
Center (reference number: 2019KYPJ090). Results will 
be published in peer- reviewed journals and presented at 
scientific meetings for academic audiences.
trial registration number NCT03992807.
IntroduCtIon
Cataracts remain the primary cause of blind-
ness, with a prevalence estimate from 20% 
among those aged 50 years to 97% in indi-
viduals aged 70 years and above.1 2 The 
current standard of care in cataract surgery 
is phacoemulsification with intraocular lens 
implantation. This procedure is the most 
commonly performed surgical intervention 
worldwide. It has led to a significant improve-
ment in patient- reported outcomes, including 
satisfaction with vision and quality of life.3 The 
broader adoption of cataract surgical services 
has resulted in a 30% reduction in the global 
prevalence of cataract- related blindness and 
associated visual impairment.4
Although modern cataract surgery is highly 
cost- effective, there is also a concern on its 
improper use or overutilisation, as there 
are no patient- related measures that are 
currently suitable for use as the surgical indi-
cation in clinical practice.5 Many countries 
have witnessed a lowering of the traditional 
visual threshold for cataract surgery (6/12 
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Figure 1 The rationale of promoting shared decision making for cataract surgery.
or worse),6–9 which have led to an increased demand for 
surgery among those at the early stages of the disease.10 
For example, the percentage of patients with preoper-
ative visual acuity (VA) better than 20/40 and 20/20 in 
the eye to be operated on was 62.5% and 2.6%, respec-
tively, in the Netherlands; 44.5% and 1.7%, respectively, 
in Sweden.11 The problem associated with shifting the 
surgical indication to those with reasonably good or almost 
no preoperative deterioration in VA, suggests the risk of 
overtreatment. This is supported by the finding from 
the European Registry of Quality Outcomes for Cataract 
and Refractive Surgery (EUREQUO) database that worse 
postoperative VA after cataract surgery was seen in >10% 
of patients with excellent preoperative VA.12 Unnecessary 
cataract surgery is also associated with a risk of surgical 
complications and surgery- related anxiety. Furthermore, 
because of the financial constraints in reimbursement 
systems,13 it is important to prioritise those with vision- 
threatening cataract, while providing decision support 
for people with mild cataract or even no inconvenience.14
The choice of when to undergo cataract surgery is, there-
fore, a complex one, and it is increasingly recognised that 
such preference- sensitive care should involve trade- offs of 
benefits and risks based on the patient’s values (figure 1). 
According to the Preferred Practice Patterns developed 
by the American Academy of Ophthalmology, the primary 
indication for cataract surgery is the visual functioning 
that no longer meets the patient’s needs.15 This statement 
reflects the need for patient- centred participation model. 
Indeed, patient involvement in shared decision making 
has been shown to improve therapeutic alliance and 
medical satisfaction.16 We have also demonstrated that 
88% of patients waiting for cataract surgery expressed a 
desire to participate in a shared decision- making process.1 
One approach to facilitate shared decision- making is 
through the use of decision aids.16 Unlike a traditional 
brochure, a decision aid is a tool that provides evidence- 
based information about the benefits and harms of treat-
ment options with easily understood images and simple 
statistics. The balanced information in decision aids is 
designed to help people make informed choices based 
on their own needs.17
We have therefore developed a decision aid for cata-
ract patients facing the decision about cataract surgery. 
The present community- based trial will investigate the 
influence of written information about cataract surgical 
outcomes among people with age- related cataract. The 
primary purpose is to assess the impact of a decision aid on 
the patient’s informed decision in the short- term. We will 
follow the participants for 1 year to assess their uptake of 
cataract surgery and patient- reported visual functioning. 
The ultimate goal is to develop and validate a tool of 
patient decision making on timely cataract surgery, as a 
strategy for a better assessment of patients’ needs and eye 
care research allocation. This strategy has an important 
implication in China’s population, which has increased 
longevity and lower fertility rate than before. The rapid 
ageing poses a challenge to the healthcare system in part 
due to surging medical expenditure.
MEthodS And AnAlySIS
Our trial protocol follows the Recommendations for 
Interventional Trials guidelines. The trial was registered 
on  Clinicaltrials. gov. It is estimated that the study dates 
would be from 1 July 2019 to 1 July 2021.
objectives
The primary goal is to evaluate whether a patient decision 
aid would help patients with age- related cataract to make 
an informed operational decision.
Specific aim 1 (primary outcome): to assess if a patient 
decision aid is superior to standard information on the 
informed decision about cataract surgery. An informed 
decision is measured by knowledge, attitudes and inten-
tions, among patients with age- related cataract.
Specific aim 2: to evaluate if a patient decision aid 
would improve participants’ performance on psychoso-
cial measures (eg, decision conflict, decision confidence, 
level of anxiety and worry) 2 weeks after the intervention.
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Figure 2 Flowchart of the trial.
Specific aim 3: to evaluate the acceptability of a patient 
decision aid among patients with age- related cataract at 
2 weeks.
Specific aim 4: to determine the impact of a patient 
decision aid on surgical uptake, the incidence of fall and 
visual functioning at 12 months.
Specific aim 5: to evaluate the cost–utility of a patient 
decision aid for patients with age- related cataract 
compared with those receiving standard information at 
12 months.
trial design
We will conduct a community- based, longitudinal, parallel- 
group, randomised controlled trial. Patient enrolment 
started in 2019 and is estimated to end in 2021. Figure 2 
summarises the design of the trial.
Setting
We will apply a random cluster sampling method, previ-
ously described in our population- based eye study.18 
In brief, the study subjects will be enrolled from a 
population- based eye disease study in Yuexiu District, 
Guangzhou, Southern China. Yuexiu District is 1 of 12 
administrative regions in Guangzhou, and has a popu-
lation of 1.17 million (National Census 2017). The 
decision to select this district is based on a stable, older 
population and socioeconomic profile representative of 
Guangzhou. Population data will be obtained from the 
Statistics Bureau of Guangzhou. In Yuexiu District, Huan-
ghua Gang Street is a community with a population of 
89 400, among which approximately 20% (n=17 880) are 
aged 50–80 years. Fifteen clusters within this street block 
are identified. These are defined geographically by Resi-
dence Administrative Committees subdivisions, and they 
each have an approximately equal number of residents 
aged 50–80 years (n=1190). With the assumption that the 
prevalence of bilateral cataract is 59% among the metro-
politan elderly Chinese population,19 we expect that the 
number of persons with bilateral cataract would be 702 in 
each cluster.
Pilot study
A pilot study including 30 subjects aged from 50 to 80 years 
was conducted in June 2019. After the pilot study, study 
interviewers and investigators shared their recruitment 
approaches and identified challenge in communicating 
the needed information during the study enrolment. We 
have found it necessary to use more than one recruiting 
approach (eg, distributing pamphlets, displaying posters 
or placing phone calls or sending messages) to enrol 
potential participants. The pilot study also highlighted 
the importance of identifying a ‘person of trust’ (eg, 
Resident Committee Manager who can build a connec-
tion between our study team and potential participants) 
to introduce the clinical trial to potential participants. 
Finally, issues identified by the pilot study was discussed 
at study investigator meetings. It was decided to use struc-
tured checklists by the interviewers to assure correct 
participant identification and to ensure completeness of 
questionnaire. The telephone interview scripts have been 
further revised to improve overall clarity.
Participants and recruitment
Population-based eye study
We will identify households with eligible subjects from the 
selected clusters, using the information of addresses; the 
name of household head and subjects; date of birth from 
the Household Resident Register Record. This infor-
mation will be further confirmed by community health 
service centres. A database including name and telephone 
numbers will be encrypted and sent to the Guangzhou 
Hengfu Social Work Service Organization (HSWSO), a 
non- profit organisation with a track record of performing 
population surveys and questionnaire interviews. The 
trained HSWSO interviewers will telephone potential 
residents to verify their residential addresses, and subse-
quently arrange appointments for the eye disease study 
at the primary eye care clinic. Written informed consent 
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will be obtained, and study coordinators will explain the 
purpose of the eye disease study as well as the benefits and 
risks of the examination.
Immediately after the eye examination at the primary 
eye care clinic, the trial investigators will briefly introduce 
the study and determine the eligibility based on a series of 
simple questions. Potential participants who meet all the 
inclusion criteria and none of the exclusion criteria will 
receive information about the trial (that they would read 
one of the two booklets to make sure the written informa-
tion about cataract and cataract surgery is clear and help 
to people with cataract). For subjects enrolled in this trial, 
written informed consent (online supplementary file 1) 
will be obtained. For each household, if one resident has 
already been successfully recruited in the trial, any other 
persons from the same household will not be invited to 
participate.
ElIgIbIlIty CrItErIA
Inclusion criteria
1. Individuals aged 50–80 years who have been resident 
in the selected study district for more than 6 months.
2. A definite diagnosis of age- related cataract.
3. Having not received cataract surgery.
4. Willing to participate in the study and provide in-
formed content.
Exclusion criteria
1. Bilateral blindness (presenting distance VA worse than 
3/60).
2. Having ocular, hearing or mental disorder precluding 
reading or telephone interview.
3. Ocular disorders other than cataract leading to perma-
nent vision loss that could not be corrected through 
cataract surgery.
4. Having cataract surgery contraindication.
IntErvEntIon And Control ArMS
1. Intervention: participants will receive a printed deci-
sion aid booklet with information about cataract sur-
gery choice.
2. Control: participants will receive a usual booklet about 
cataract and cataract surgery.
After enrolment, eligible participants who provide 
written informed consent for this trial will complete an 
interviewer- administered questionnaire. This face to face 
survey is to obtain baseline information (T1) including 
demographic characteristics, education, literacy, patient- 
reported visual function, conceptual knowledge about 
cataract surgery and decision- making factors (stage of 
decision making, intentions and attitudes towards cata-
ract surgery). After the baseline assessment, the partici-
pants will be consecutively randomly assigned to one of 
the two trial arms in a ratio of 1:1 with permuted block 
sizes of four and eight. They will either receive the inter-
vention using a decision aid booklet or the one using 
traditional cataract booklet, and they will be asked to 
carefully read the brochure at home before the 2- week 
telephone interview. The interviewers’ performance will 
be regularly monitored throughout the survey to ensure 
the interviewer read off a list of questions from a struc-
tured script.
At 2 weeks, the HSWSO interviewers masked to the 
study allocation will initiate a structured telephone inter-
view to obtain information on outcome measures (T2). 
The participants will be asked if they have already read 
the study materials. If not, an arrangement will be made 
to call back at another time within 1 week. If they have 
already read the booklet, a 45- min telephone survey will 
be conducted using standard wording. The interviewers’ 
performance will be regularly monitored throughout the 
study to ensure the interviewer read off a list of questions 
from a structured script.
long-term follow-up
A follow- up assessment will be collected at 12 months 
after the intervention. The HSWSO interviewers will call 
patients to remind them about the study assessment and 
confirm their operational status, fall event, self- assessed 
visual function, health status and ophthalmology related 
and other healthcare use in the past 12 months and work 
during the last 4 weeks.
decision aid booklet
The patient decision aid booklet was developed for this 
study and is designed to inform but not to influence cata-
ract patients either towards or away from choosing surgery. 
The content and presentation were developed based on 
the understanding of cataract- related information, areas 
of concern or confusion and views on communication 
among aged patients. Independent epidemiological, clin-
ical and communication experts reviewed the decision 
aid booklet, and thoroughly piloted for its acceptability 
and comprehension.
Table 1 summarises the topics covered in the two book-
lets. The usual booklet includes standard general infor-
mation developed by the National Eye Institute (NEI) for 
patients with age- related cataract, and it has been imple-
mented in clinical practice. The content of the usual 
booklet consists of the following:
1. Description and visual impact of age- related cataract.
2. A statement that age- related cataract is treatable only 
with surgery, and there is a high rate of success.
3. Description of the cataract surgical procedure.
4. A statement that the cataract surgery is indicated only 
when visual function no longer meets the patient’s 
needs.
PrE-EnrolMEnt EyE ExAMInAtIon
We followed a population- based study protocol used in 
our previous study20 for the current eye examination and 
questionnaire data collection in our population- based 
eye study programme.
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Table 1 Summary of topics covered in the decision aid and 
control booklets
Decision aid booklet Control booklet
Front cover: title+image Front cover: title+image
Introduction to purpose of 
decision aid
Introduction to purpose
Basic knowledge Basic knowledge
Benefits associated with 
surgery
  
Risks associated with surgery   
Benefits associated with 
delaying surgery
  
Risks associated with delaying 
surgery
  
Suggested indication for 
cataract surgery
Suggested indication for 
cataract surgery
Needs and values clarification 
exercise
  
Additional information Additional information
References References
Glossary Glossary
Back cover: further information 
sources
Back cover: further 
information sources
visual acuity
Distance presenting visual acuity (PVA) and best- 
corrected visual acuity will be measured using an Early 
Treatment Diabetic Retinopathy Study (ETDRS) chart 
(Precision Vision, 213 Villa Park, Illinois, USA) with stan-
dard illumination.
Intraocular pressure measurement
Intraocular pressure (IOP) will be measured by auto-
mated non- contact tonometer (TX- F; Canon, Tokyo, 
Japan) accordingly, and individuals whose IOP ≥21 mm 
Hg will be advised to have a further examination to 
exclude glaucoma or other ocular diseases.
lens opacities Classification System III
Slit- lamp images will be collected using a slit- lamp micro-
scope (model BQ-900; Haag- Streit, Köniz, Switzerland) 
under pupil dilation with 0.5% tropicamide and 0.5% 
phenylephrine hydrochloride eye drops, and the severity 
of cataract will be graded using Lens Opacities Classi-
fication System III (LOCS III) system. A well- trained 
ophthalmologist will make the grading of cataract by 
using standard photographic slides for nuclear opales-
cence (NO), nuclear colour (NC), cortical (C) and poste-
rior subcapsular (P) cataract. Individuals who meet the 
following criteria will be diagnosed as age- related cata-
ract: NC/NO ≥2, C≥C2 or P≥1. Different studies have 
employed different arbitrary LOCS III cut- off points,21 
and the ones used in this study may enable us to include 
patients with a very mild stage of cataract. We have chosen 
the P score of 1 as the cut- off, given that previous studies 
found that posterior subcapsular cataract has a more 
significant visual impact than the other cataract types.22
Fundus examination
Fundus photo will be taken by fundus photography (Zeiss 
FF450, Zeiss, Oberkochen, Germany). Each photo will be 
reviewed to exclude any sight- threatening retinal diseases.
rAndoMISAtIon And MASkIng
Computer- generated randomisation sequences will be 
made by a statistician who has no contact with partici-
pants before beginning enrolment. Participants will be 
allocated to either the intervention or control arm in 
a 1:1 ratio with permuted block sizes of four and eight. 
Both the patient decision aid booklets and standard 
education booklets are printed in the same size and have 
the same cover with the same title ‘Cataract: what is the 
best time to have surgery?’. An independent coworker not 
involving in this study put each booklet into a sequentially 
numbered and opaque folder and seal it, using an allo-
cation sequence provided by the statistician. Due to the 
nature of the intervention, blinding of participants is not 
possible, but they will be instructed to take home a sealed 
folder containing a booklet and they will not be given any 
specific information on the type of booklet they receive. 
Investigators responsible for recruiting participants and 
interviewers who supervise the preintervention question-
naire (T1) will not be aware of the allocation, in order to 
ensure allocation concealment. HSWSO interviewers who 
oversee the telephone interviews (T2, T3), will also not 
be aware of the assignment to interventions, and they will 
ask questions using standardised wording with precoded 
responses within a supervised environment.
PrEIntErvEntIon quEStIonnAIrE SurvEy (t1)
An interviewer- administered questionnaire will be used to 
obtain information on health literacy and demographic 
and socioeconomic data. The shortened version of the 
Chinese Health Literacy Questionnaire (19 items)23 
will be used to assess the level of health literacy. Other 
sociodemographic information includes age, gender, 
education, occupation, stage of decision making about 
surgery,24 25 basic conceptual knowledge, attitudes26 27 and 
intentions.28 29
dAtA CollECtIon
Eye examination data will be collected by local research 
staff, including grading of cataract and PVA. Trained 
HSWSO interviewers will conduct a telephone survey 
to collect postintervention outcome data 2 weeks after 
randomisation, and will carry out further brief telephone 
surveys for long- term follow- up at 1- year postintervention.
The HSWSO interviewers do not belong to the research 
team. The interviews will be conducted within a super-
vised environment in which interviewer performance is 
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monitored to ensure scripts are read as written. All survey 
questions use standardised wording, and the questions 
are designed such that the study group allocation is 
unknown to the interviewer.
outCoME MEASurES
Primary outcome
The primary outcome is an informed choice about 
cataract surgery (adequate knowledge and consistency 
between attitudes and cataract surgery intentions).30–32 
An informed decision will be assessed as a dichotomous 
outcome combining measures of knowledge, attitudes 
and intentions 2 weeks after intervention. A participant 
is judged to have made an informed choice if he/she has 
adequate knowledge and his/her attitudes and intentions 
are consistent.30–32
We use a competency- based approach to evaluate 
knowledge of cataract surgery.33 34 The knowledge ques-
tionnaire involves 12 items to measure both the concep-
tual and numerical information, following the methods 
used in previous decision aid trials.32 A person will be 
determined to have adequate knowledge score based on 
a marking scheme developed a priori. Attitudes towards 
cataract surgery will be assessed with a theory- based 
generic screening attitude scale. Intentions about having 
cataract surgery will be measured by a single item, using 
a set of five response options. An intention will be classi-
fied as either a positive (‘definitely will’ or ‘likely to’) or 
a negative one (‘unsure’, ‘not likely to’ or ‘definitely will 
not’).
Secondary outcomes
Perceived importance of surgical benefit/harms (T2)
Purpose- developed items will be used to ask partici-
pants about their perceptions of the importance of 
specific outcomes32 in their decision- making about cata-
ract surgery. The following questions will be asked: ‘In 
deciding whether to have timely surgery, how important 
is it for you to consider the chance of vision improvement 
after surgery so as to meet the need of your daily activ-
ities?’ and ‘In deciding whether to have timely surgery, 
how important is it for you to consider the chance of 
no improvement after surgery, or even deterioration in 
vision due to complications of surgery?’. The answers are 
four response categories ranging from ‘very important’ to 
‘not at all important’.
Perceived personal chances of surgical benefit/harms (T2)
Participants will be asked about their perceived personal 
likelihood of experiencing specific outcomes32 if they 
have cataract surgeries, compared with an average patient 
who had undergone cataract surgery. The following ques-
tions will be asked: ‘What is your perceived chance of 
vision improvement after surgery relative to the average 
person?’ and ‘What is your perceived chance of no 
vision improvement after surgery, or even deterioration 
in vision due to surgical complications, relative to the 
average person?’. The answers are five response catego-
ries ranging from ‘much lower’ to ‘much higher’.
Decisional conflict (T2)
Decisional conflict will be assessed using a 16- item Deci-
sional Conflict Scale.35 Scores range from 0 (no decisional 
conflict) to 100 (extremely high decisional conflict).
Decisional confidence (T2)
Decisional confidence will be assessed using an 11- item 
Decision Self Efficacy Scale.36 Score ranges from 0 (not at 
all confident) to 4 (very confident) for each item.
Time perspective (T2)
This outcome will be assessed using a 4- item short form 
of the Consideration of Future Consequences Scale, with 
five response categories ranging from strongly agree to 
strongly disagree.37 38
Anticipated regret (T2)
Two items from a validated scale will measure anticipated 
regret about having cataract surgery (action regret) and 
about not having cataract (inaction regret).39 40
Cataract worry and anxiety (T2)
A single item will measure participants’ level of worry 
about having a cataract, using four verbal response cate-
gories ranging from not worried at all to very worried.32 
Anxiety will be measured with a 6- item short form.41 The 
total score ranges from 20 to 80.
Booklet utilisation and acceptability (T2)
Acceptability and utilisation of materials will be assessed 
by questionnaire items measuring how participants used 
and evaluated the decision aid booklets.32 42
Undergoing cataract surgery (T3)
Self- reported undergoing cataract surgery will be assessed 
via a telephone survey at 1 year.
Decision regret (T3)
The Decision Regret Scale32 will measure participants’ 
level of regret regarding their initial decision whether to 
have cataract surgery or not.
Visual functioning (T1, T3)
The visual function will be assessed using the Catquest 
9SF questionnaire.43
Fall questionnaire (T3)
At 12 months, the following question will be asked by the 
HSWSO interviewers to collect information related to 
falls: ‘Did you have any fall in the past 12 months whereby 
you landed on the ground or floor?’. The participant will 
be classified as a ‘faller’ if a fall would happen in the past 
12 months. Otherwise, he or she will be classified as a 
‘non- faller’.44
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Heath-related quality of life (T1, T3)
We obtained the authorisation of the simplified Chinese 
version of the EQ- 5D- 5L telephone interview script from 
the EuroQol research foundation.45 The questionnaire 
is a standardised measure of health status including 
five dimensions: mobility, self- care, usual activities, 
pain/discomfort and anxiety/depression. Each of the 
five dimensions is divided into five levels of perceived 
problems.46
Costs (T1, T3)
The English version of Treatment Inventory of Costs in 
Patients with psychiatric disorders (TIC- P) question-
naire (2018) authorised by the Institute for Medical 
Technology Assessment was translated into Chinese by a 
certified translation agency. The questionnaire is about 
participants’ use of care in the past 12 months and about 
work during the last 4 weeks. Direct and indirect medical 
and non- medical costs are collected with the TIC- P ques-
tionnaire.47 48
AdhErEnCE IMProvEMEnt ProvIdEd to both ArMS
To improve the adherence of the participants enrolled 
in this particular trial, a face- to- face adherence reminder 
session will take place after the eye examination. This 
session will include the followings:
1. Highlighting the importance of following study guide-
lines for adherence to this study.
2. Detailed explanations about the trials, mentioning 
that there would be an about 45- minute telephone in-
terview.
3. Emphasising the importance of calling the study staff 
if they have any questions about the information in the 
decision aid booklet.
4. Noting that participants will have an opportunity to ask 
questions and critical messages.
tIME SChEdulE
Schedule of enrolment, interventions, assessments and 
visits for participants are shown in the schematic diagram 
in table 2.
SAMPlE SIzE
The primary analysis will be comparing two groups on the 
proportion of patients who make an informed choice. We 
aimed to recruit 386 participants in each group (772 in 
total) based on the following assumptions.
Provided that 10% of participants assigned to control 
group would make an informed choice 2 weeks after the 
intervention, and in order to detect a group difference of 
10% in the primary outcome, we need 219 participants 
per study group to achieve 80% power (α of 5% two- sided 
test). Allowing for 10% loss to follow- up at 2 weeks, we 
need to recruit 244 participants in each group (488 in 
total).
Further, assuming that 30% of participants assigned 
to control group would receive cataract surgery 1 year 
after the intervention, and in order to detect a group 
difference of 10%, we need a total of 313 participants 
per group. Assuming an additional 10% loss to follow- up 
(in addition to the 10% loss to follow- up at 2 weeks) at 
1 year after the intervention, we needed to recruit 386 
participants in each group (772 in total). This sample size 
is larger than the one calculated based on the primary 
endpoint.
AdvErSE EvEntS
Adverse events (AEs) are identified during the face- to- 
face interview, and telephone interviews at the time of 
study follow- up visits. Severe AEs and specific procedure- 
associated AEs are reported to the clinical research 
centre of Zhongshan Ophthalmic Center (ZOC) within 
24 hours. Only study- related AEs will be reported to the 
Ethics Committee. If AEs occur, the safety of the partic-
ipants would be the first concern, and any treatment 
emergent symptom will be referred to a physician or a 
psychologist.
dAtA MAnAgEMEnt
All telephone interviews will be administered through 
a computer- assisted telephone interview (CATI) 
programme. The CATI and quality control processes 
ensure that interviewers do not skip any statements while 
providing information to respondents.
The study investigators will ensure that the confidenti-
ality of the patients’ data is preserved. Individual partici-
pant data will not be disclosed outside and will not appear 
on any publications, and the data will be de- identified 
before it passed to the study statistician. Printed records 
with identifiable data will be stored in locked cabinets, 
whereas electronic records will be password protected on 
a secure server for 10 years and then securely destroyed.
Data entry and management will be conducted using 
an Electronic Data Capture System by data administra-
tors. If there are any detections of omissions, errors or 
items requiring clarification or changes to Case report 
form (CRF), the item will be written down on the data 
query form and forwarded to the clinical monitor for 
processing. Data correction and validation will be made 
according to International Conference on Harmoniza-
tion guidelines.
Compliance of regulatory documents and study data 
accuracy and completeness will be maintained through an 
internal study team quality assurance process. Data will be 
de- identified before is it passed to the statistician. Records 
containing identifiable data will be stored in locked cabi-
nets at the ZOC with restricted access. Digital data will be 
password protected and stored on a secure server at the 
ZOC for 10 years and then securely destroyed. Only the 
investigators will have access to the data.
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Table 2 Study schedule
Timing −1 week Baseline 2 weeks 1 year
Recruitment ×
Baseline information Basic characteristics   ×
Health literary and education   ×
Stage of decision making   ×
Quality of visual functioning   × ×
Quality of life   × ×
Medical costs and productivity losses   × ×
Major outcomes Knowledge Knowledge about cataract   × × ×
Knowledge about timing for 
cataract surgery
  × ×
Knowledge related to undergoing 
surgery (conceptual)
  × × ×
Knowledge related to undergoing 
surgery (numerical)
  × ×
Knowledge related to delaying 
surgery (conceptual)
  × × ×
Knowledge related to delaying 
surgery (numerical)
  × ×
Intentions for surgery   × × ×
Attitudes for surgery   × × ×
Secondary outcomes Perceived importance of benefits/risks   ×
Perceived changes of benefits/risks   ×
Decision conflict   ×
Decision self- efficacy   ×
Time perspective   ×
Anticipated regret   × ×
Worry   × ×
Anxiety   × ×
Booklet utilisation/acceptability   ×
Long- term 
secondary outcomes
Decision regret   ×
Uptake of cataract surgery   ×
Fall question   ×
AnAlySIS PlAn
Analysis will be carried out blinded to intervention 
status. The primary analysis is to compare the propor-
tions of informed decision between two study groups. 
We will perform intention to treat analysis, in which all 
randomised participants will be included in the primary 
analysis, which will be undertaken when the last partic-
ipant has completed the 2- week follow- up. The results 
of the primary analysis will be published in appropriate 
journals.
Dichotomous outcomes will be analysed using a χ2 test, 
and continuous outcomes using a two- sample t- test or 
Wilcoxon rank- sum test. We will use generalised linear 
models with Poisson regression to estimate the relative 
risk associated with the intervention. All reported p 
values are two- sided, with a p value <0.05 considered as 
significant. We will use multiple imputation techniques, 
which creates 20 copies of the data by chained equations 
or sensitivity analysis to handle missing values. Analyses 
will be carried out using Stata V.13.1 software.
The economic evaluation will be carried out by cost–
utility analysis to determine the cost in terms of utili-
ties (quality of life). Direct and indirect medical and 
non- medical expenses will be considered according to 
a societal perspective and be calculated based on the 
consumer price index. The utility value is assessed with 
the EQ- 5D- 5L value set.45 The incremental cost–utility 
ratio (ICUR) is a standard application in cost–utility anal-
ysis and defined as the ratio between the difference in 
total costs and the difference in quality- adjusted life years 
between the two trial arms. A 95% CI of the ICUR will be 
calculated using 5000 bootstrap replications. Sensitivity 
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analysis will be performed to study the effect of uncertain 
main cost.49
trIAl MonItorIng
The independent steering committee will oversee the 
study design, delivery, quality assurance and data anal-
ysis. The data monitoring committee will review reports 
including recruitment and drop- out rates, adherence to 
SOPs and adverse events.
PAtIEnt And PublIC InvolvEMEnt
We have established a Patient Advisory Committee (PAC) 
to improve the design of the patient decision aid and 
the design of the current study. The PAC group includes 
three patients with age- related cataract who had interest 
in how different types of education booklets might have 
an impact on patients’ decision. We had a meeting with 
the PAC, who provided feedback on the study design and 
suggestions on the interviewer- administered question-
naires. In addition, our study results will be disseminated 
to primary eye care clinics to share information with study 
participants and patients.
EthICS And dISSEMInAtIon
This protocol (version 1.0; 9 July 2019) and the template 
informed consent forms (version 1.0; 9 July 2019) were 
reviewed and approved by the Ethics Committee of 
Zhongshan Ophthalmic Center (approval number: 
2019KYPJ090). Any protocol modifications will be sent 
for review by the ethics committee. Written informed 
consent will be provided from all participants during the 
visit for an eye examination at the study site, as well as from 
enrolled subjects before trial intervention. Explaining the 
study and obtaining consent will facilitate comprehension 
and reduce the unnecessary burden entailed in a written 
consent form. There will be plain- language written study 
information to inform the participants of the right to 
refuse participation or withdraw consent. The results of 
the trial will be published in peer- reviewed journals and 
presented at scientific meetings for academic audiences. 
The trial will be reported following the Consolidated 
Standards of Reporting Trials statement.
dISCuSSIon
The findings from this trial may provide high- quality 
evidence to determine whether a patient decision aid 
is useful for patients with age- related cataract. It is 
important to note that providing the patients the oppor-
tunity to make informed choices, based on the balanced 
information of the benefits and risks of different treat-
ment options, is the goal of facilitating decision making. 
Thus, the key performance indicators of our intervention 
should be informed choice, irrespective of whether the 
eventual long- term decision is to undergo surgery or not.
To the best of our knowledge, there has been no publi-
cation regarding the impact of a patient decision aid on 
medical decisions in China. Patient decision- making tool 
has not been previously delivered to the general public 
in the Chinese population, and it is plausible that these 
people may still be accustomed to the usual booklet with 
standard information. As such, we are interested in the 
comparison of the effects of decision aid booklet with the 
usual booklet. Another essential purpose of our study is to 
know if the patient decision aid is cost- effective compared 
with routine care, to permit generalisation of our finding 
to the clinical practice.
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